TabletsClinical Overview
Calcium Acetate Tablets (667mg, providing 169mg elemental calcium) is an oral intestinal phosphate binder on the WHO Model List framework. In the acidic stomach and duodenum, calcium acetate binds dietary phosphorus to form insoluble calcium phosphate complexes that are excreted in feces, preventing phosphate absorption without excessive calcium absorption. Indicated for control of hyperphosphatemia in adult and pediatric patients with End-Stage Renal Disease (ESRD) / Chronic Kidney Disease on hemodialysis.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally strictly WITH MEALS: 1 to 2 tablets with each meal (swallow whole with water). Taking on an empty stomach is completely ineffective. Titrate dose based on serum phosphorus levels (target 3.5-5.5 mg/dL).
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Mild hypercalcemia, constipation, nausea, flatulence, abdominal discomfort. Rare/Severe: Severe hypercalcemia, calciphylaxis, and metastatic vascular calcification.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Must be taken WITH meals. Regularly monitor serum calcium and phosphorus twice monthly. Contraindicated in hypercalcemia. Discontinue if serum calcium exceeds 10.5 mg/dL.
Medical Disclaimer: Statutory Nutritional & Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice or clinical dietetic guidance. Dietary supplements, micronutrients, parenteral electrolytes, and specialized clinical nutrition should be used under the supervision of a registered medical practitioner or clinical nutritionist.
Calcium 500mg and Vitamin D3 250IU Tablets
Cholecalciferol (Vitamin D3 Drops 400 IU/ml, 800 IU/ml) is a physiological pediatric liquid formulation on the WHO Model List of Essential Medicines. Promotes normal bone growth and dentition in infants and children. Indicated for prevention of nutritional rickets and maintenance of healthy skeletal development in breastfed infants.
Pyridoxine Hydrochloride 10mg, Doxylamine 10mg and Folic Acid 2.5mg Tablets
Folic Acid (5mg, 15mg) and L-Methylfolate Calcium (1mg, 2.8mg, 7.5mg Tablets) is an essential water-soluble B-vitamin and active tetrahydrofolate derivative on the WHO Model List of Essential Medicines. L-Methylfolate is the active methylated metabolite (5-MTHF) that crosses the blood-brain barrier directly without requiring enzymatic reduction by methylenetetrahydrofolate reductase (MTHFR). Transports one-carbon units for purine and thymidylate synthesis, essential for DNA replication, cell division, and homocysteine remethylation. Indicated for prevention of neural tube defects (spina bifida, anencephaly) in pregnancy, treatment of folate deficiency megaloblastic anemia, hyperhomocysteinemia, and adjunctive therapy in depression.
Folic Acid Tablets 5 mg
Folic Acid (5mg, 15mg) and L-Methylfolate Calcium (1mg, 2.8mg, 7.5mg Tablets) is an essential water-soluble B-vitamin and active tetrahydrofolate derivative on the WHO Model List of Essential Medicines. L-Methylfolate is the active methylated metabolite (5-MTHF) that crosses the blood-brain barrier directly without requiring enzymatic reduction by methylenetetrahydrofolate reductase (MTHFR). Transports one-carbon units for purine and thymidylate synthesis, essential for DNA replication, cell division, and homocysteine remethylation. Indicated for prevention of neural tube defects (spina bifida, anencephaly) in pregnancy, treatment of folate deficiency megaloblastic anemia, hyperhomocysteinemia, and adjunctive therapy in depression.
Syrup of Iron and Folic Acid in a flavoured Base
Oral Iron and Folic Acid Formulations (Ferrous Ascorbate 100mg, Carbonyl Iron 50mg/100mg, Ferrous Asparto Glycinate with Folic Acid 1.5mg, L-Methylfolate, Zinc, and Vitamin B12) is an evidence-based hematinic on the WHO Model List of Essential Medicines. Ferrous ascorbate combines synthetic ascorbic acid (vitamin C) with divalent iron (Fe2+), maintaining iron in its soluble, highly absorbable ferrous state across duodenal pH and dramatically enhancing bioavailability while minimizing gastric mucosal irritation. Carbonyl iron provides ultra-pure elemental iron with delayed gastric acid dissolution, virtually eliminating nausea and toxicity. Folic acid and B12 support DNA synthesis and normoblastic erythropoiesis. Indicated for prevention and treatment of iron deficiency anemia, nutritional deficiency in pregnancy and lactation, and chronic menorrhagia.